Skip to content

Released May 13, 2014, before the open

10-Q filed May 13, 2014, 43 days after period end · 0001144204-14-029745

Q1 2014 · 10-Q
Revenue—
Net Income-$5.27MN/M vs Q1 2013N/M vs Q4 2013
EPS Diluted-$0.41N/M vs Q1 2013no prior Q4 2013 on file
Operating Income-$5,292,622N/M
Operating Cash Flow-$3,217,654N/M
Free Cash Flowderived-$3,219,520N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2014Q1 2013Q1 2012
Net Income-$5.27M-$1.35M-$61.23K
EPS Diluted-$0.41-$0.30-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR